Table 1.
Characteristics of the study population and results of histological examinations of the samples obtained by unenhanced ultrasonography guidance (pre-contrast agent), and those obtained by CEUS guidance collected in the points of the mass enhanced by the contrast agent (contrast agent +) and in the points not enhanced by the contrast agent (contrast agent −)
Patient ID | Age | Sex | Pre-contrast agent | Contrast agent + | Contrast agent − |
---|---|---|---|---|---|
1 | 52 | M | Pleomorphic rhabdomyosarcoma | Pleomorphic rhabdomyosarcoma | Pleomorphic rhabdomyosarcoma |
2 | 52 | M | Fibroadipose tissue (lipoma) | Fibroadipose tissue (lipoma) | Fibroadipose tissue (lipoma) |
3 | 72 | M | Skeletal muscle tissue | Desmoid fibromatosis | Skeletal muscle tissue |
4 | 56 | M | Myxoid liposarcoma | Myxoid liposarcoma | Myxoid liposarcoma |
5 | 32 | M | Neurofibroma | Neurofibroma with focal atypia and no mitotic activity | Neurofibroma with focal atypia and no mitotic activity |
6 | 35 | F | Desmoid fibromatosis | Desmoid fibromatosis | Desmoid fibromatosis |
7 | 56 | F | Nodular fascitis | Nodular fascitis | Nodular fascitis |
8 | 36 | M | Nodular fascitis | Nodular fascitis | Nodular fascitis |
9 | 35 | M | Neurofibroma | Neurofibroma with focal atypia and no mitotic activity | Neurofibroma |
10 | 32 | F | Localization of melanoma | Localization of melanoma | Localization of melanoma |
11 | 72 | M | Localization of melanoma | Localization of melanoma | Localization of melanoma |
12 | 80 | F | Adipose tissue without atypia | Adipose tissue without atypia | Adipose tissue without atypia |
13 | 76 | M | Blood material | Fibrin-blood material | Non-malignant vascular proliferation |
14 | 25 | M | Cartilaginous neoplasm without atypia | Cartilaginous neoplasm without atypia | Cartilaginous neoplasm without atypia |
15 | 75 | F | Atypical lipomatous tumor | Atypical lipomatous tumor | Atypical lipomatous tumor |
16 | 77 | M | Desmoid fibromatosis | Desmoid fibromatosis | Skeletal muscle tissue |
17 | 54 | M | Decubital fascitis | Decubital fascitis | Decubital fascitis |
18 | 72 | F | Granular cell tumor | Granular cell tumor | Granular cell tumor |
19 | 58 | F | Non-Hodgkin lymphoma | Non-Hodgkin lymphoma | Non-Hodgkin lymphoma |
20 | 62 | F | Elastofibroma dorsi | Elastofibroma dorsi | Elastofibroma dorsi |
21 | 66 | M | Schwannoma | Schwannoma | Schwannoma |
22 | 47 | F | Chondroma | Chondroma | Chondroma |
23 | 59 | M | Skeletal muscle and adipose tissue | Adipose tissue and fibrin leukocyte material | Adipose tissue and fibrin leukocyte material |
24 | 77 | F | Solitary fibrous tumor | Solitary fibrous tumor | Solitary fibrous tumor |
25 | 61 | F | Myxoid mesenchymal tumor | Myxoid mesenchymal tumor | Myxoid mesenchymal tumor |
26 | 71 | M | Myxoid liposarcoma | Myxoid liposarcoma | Myxoid liposarcoma |
27 | 48 | M | Neurofibroma | Neurofibroma with focal atypia and non-mytotic activity | Neurofibroma |
28 | 48 | F | Nodular fascitis | Nodular fascitis | Nodular fascitis |
29 | 57 | M | Myxoid liposarcoma | Myxoid liposarcoma | Myxoid liposarcoma |
30 | 58 | F | Localization of melanoma | Localization of melanoma | Localization of melanoma |
31 | 55 | F | Elastofibroma dorsi | Elastofibroma dorsi | Elastofibroma dorsi |
32 | 68 | M | Atypical lipomatous tumor | Myxoid liposarcoma | Atypical lipomatous tumor |
33 | 58 | M | Blood material | Non-malignant vascular proliferation | Fibrin-blood material |
34 | 60 | F | Schwannoma | Schwannoma | Schwannoma |
35 | 88 | M | Undifferentiated pleomorphic sarcoma | Undifferentiated pleomorphic sarcoma | Undifferentiated pleomorphic sarcoma |
36 | 43 | F | Non-Hodgkin lymphoma | Non-Hodgkin lymphoma | Non-Hodgkin lymphoma |
37 | 68 | M | Solitary fibrous tumor | Solitary fibrous tumor | Solitary fibrous tumor |
38 | 76 | M | Mesenchymal malign neoplasm | Mesenchymal malign neoplasm | Mesenchymal malign neoplasm |
39 | 41 | F | Chondroma | Chondroma | Chondroma |
40 | 54 | F | Fibroadipose tissue (lipoma) | Fibroadipose tissue (lipoma) | Fibroadipose tissue (lipoma) |